NCT01026545 - Multiple Oral Dose Safety, Tolerability And Pharmacokinetic Study Of PF-04287881 In Healthy Adult Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Respiratory Tract Infections

Interventions

DRUG

PF-04287881

500 mg once daily for 10 days

DRUG

Placebo

To match 500 mg dose once daily for 10 days

DRUG

PF-04287881

750 mg once daily for 10 days

DRUG

Placebo

To match 750 mg dose once daily for 10 days

DRUG

PF-04287881

1100 mg once daily for 10 days

DRUG

Placebo

To match 1100 mg dose once daily for 10 days

DRUG

PF-04287881

Optional cohort with dose not greater than 1100 mg

DRUG

Placebo

Optional cohort to match dose not greater than 1100 mg

DRUG

PF-04287881

750 mg dose once daily for 10 days

DRUG

Placebo

To match 750 mg dose once daily for 10 days

DRUG

PF-04287881

1100 mg dose once daily for 10 days

DRUG

Placebo

To match 1100 mg dose once daily for 10 days

Trial Locations (1)

06511

Pfizer Investigational Site, New Haven